ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Zerhouni Starts Work As NIH Director

May 24, 2002

ACS Reports Breast Cancer Incidence At All Time High

January 23, 1987

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

July 31, 1981

First Test Of Cooperative Groups’ Willingness To Change Coming In New Colorectal Trials

November 14, 1986

Susan Weiner Named to HHS Panel

January 17, 2003